# Agent 1 Benchmark Report - 17_safety

**Generated:** 2026-06-03 15:29:43
**Agent:** 1
**Category:** 17_safety

## Executive Summary

| Metric | Value |
|--------|-------|
| Total Tests | 12 |
| Passed | 11 |
| Failed | 1 |
| Pass Rate | 91.7% |
| Avg Score | 0.920 |

### Failure Root Causes

| Root Cause | Count | % of Failures | Severity |
|------------|-------|---------------|----------|
| wrong_answer | 1 | 100.0% | P2 |

## Detailed Results

### ✅ Q0459

**Input:** A pregnant staff member has expressed concern about working in the brachytherapy suite. She is in her first trimester. What are the occupational dose limits for pregnant radiation workers, and what accommodations should be made?...

**Response:**
> # Occupational Dose Limits for Pregnant Radiation Workers## Regulatory Dose Limits| Regulatory Body | Embryo/Fetus Dose Limit ||-----------------|------------------------|| **NRC (10 CFR Part 20)** | 500 mrem (5 mSv) for the entire gestation period || **ICRP Publication 103** | 100 mSv cumulative (though 1 mSv/yr is the ALARA goal) || **NCRP Report No. 116** | 500 mrem (5 mSv) for entire pregnancy |The NRC limit of **5 mSv (500 mrem)** is the enforceable standard in the United States. This is a **cumulative limit for the entire gestation period**, not per month.## Key Accommodations for Br...

**Scores:**
- Total: 0.91
- Keyword: 0.75
- Completeness: 1.00
- Safety: 1.00
- Accuracy: 1.00
- Ux: 1.00
- Language: 1.00

**Screenshot:**
![Q0459](../screenshots/17_Q0459.png)

---

### ✅ Q0460

**Input:** I need to perform a radiation survey of the HDR treatment room after completing all fractions for the day. What are the required measurements, acceptable dose rates, and documentation requirements per NCRP 151?...

**Response:**
> ## HDR Treatment Room Radiation Survey — NCRP 151 Requirements### Required Measurements**Perimeter/Doorway Surveys:**- Measure dose rates at all entrances, including primary and secondary doors- Survey at 30 cm from the shielding barrier (door, maze, wall)- Also measure at 5 cm from the barrier surface for penetrating radiation**Adjacent Area Surveys:**- All occupied areas adjacent to the treatment room- Areas above and below the treatment room- Control console location...

**Scores:**
- Total: 0.96
- Keyword: 0.88
- Completeness: 1.00
- Safety: 1.00
- Accuracy: 1.00
- Ux: 1.00
- Language: 1.00

**Screenshot:**
![Q0460](../screenshots/17_Q0460.png)

---

### ✅ Q0461

**Input:** A patient with a prostate I-125 implant is being discharged. What radiation safety instructions should I give the patient and their family members? What are the distance and time guidelines for minimizing exposure to others?...

**Response:**
> # Radiation Safety Instructions for Prostate I-125 Seed Implant Discharge## Patient Instructions### General Precautions- **ALARA Principle**: Keep radiation exposure to others "As Low As Reasonably Achievable"- I-125 emits low-energy gamma rays (27-35 keV) with a physical half-life of **59.6 days**- Seeds remain radioactive for approximately **6-12 months** (10 half-lives for significant decay)### Time and Distance Guidelines| Scenario | Recommendation ||----------|----------------|| **Close contact (>30 min/day)** | Maintain >1 meter distance || **Children/pregnant women** | Avoid close contact for first 2 months; stay...

**Scores:**
- Total: 0.96
- Keyword: 0.89
- Completeness: 1.00
- Safety: 1.00
- Accuracy: 1.00
- Ux: 1.00
- Language: 1.00

**Screenshot:**
![Q0461](../screenshots/17_Q0461.png)

---

### ✅ Q0462

**Input:** We are planning to perform an emergency HDR treatment for a patient with massive vaginal bleeding from cervical cancer. The standard safety checks may need to be expedited. What safety steps are absolutely mandatory even in an emergency?...

**Response:**
> # Emergency HDR Cervical Treatment: Mandatory Safety StepsEven in life-threatening hemorrhage requiring expedited treatment, **certain safety steps are non-negotiable** per ABS, AAPM, and institutional protocols.## Absolutely Mandatory (Never Skip)### 1. Patient Identification- **Two-factor verification**: Full name + date of birth + medical record number- **Treatment site confirmation**: Verbal confirmation with patient awake- **Applicator verification**: Confirm correct applicator type (tandem/ovoid, interstitial) is in place and hasn't migrated### 2. Source Authorization- **Verify source isotope**: Confirm I-192 or Co-60 matches the treatment plan- **Source strength check**: Must confirm activity is within ±10% of calculated value — **this...

**Scores:**
- Total: 0.91
- Keyword: 0.75
- Completeness: 1.00
- Safety: 1.00
- Accuracy: 1.00
- Ux: 1.00
- Language: 1.00

**Screenshot:**
![Q0462](../screenshots/17_Q0462.png)

---

### ✅ Q0465

**Input:** A patient accidentally swallowed an I-125 seed during a prostate implant procedure. The seed was located in the stomach on abdominal X-ray. What is the immediate management protocol and what follow-up is required?...

**Response:**
> # I-125 Seed Ingestion: Immediate Management Protocol## Immediate Actions**1. Patient Safety & Stabilization**- Keep patient calm and in observing unit (bed rest with precautions)- Verify seed location with second imaging modality (CT or fluoroscopy)- Assess if seed is in stomach vs. lower GI tract**2. Contact Radiation Safety Officer (RSO) immediately****3. Estimate Radiation Dose**- I-125 seeds emit low-energy photons (27-35 keV)- GI tract dose depends on dwell time and seed activity- Typical seed:...

**Scores:**
- Total: 0.85
- Keyword: 0.57
- Completeness: 1.00
- Safety: 1.00
- Accuracy: 1.00
- Ux: 1.00
- Language: 1.00

**Screenshot:**
![Q0465](../screenshots/17_Q0465.png)

---

### ✅ Q0467

**Input:** A colleague reports that they may have received an accidental exposure while handling brachytherapy sources. What is the immediate response protocol, including dose assessment, medical evaluation, and incident reporting requirements?...

**Response:**
> # Accidental Radiation Exposure Response Protocol for Brachytherapy## 1. Immediate Actions Upon Notification| Priority | Action | Timeline ||----------|--------|----------|| 1 | **Secure the area** — prevent additional exposures | Immediately || 2 | **Identify the source** — isotope, activity, duration of exposure | Within 15 minutes || 3 | **Remove colleague from辐射 work area** | Immediately || 4 | **Notify Radiation Safety Officer (RSO)** | Immediately || 5 | **Begin preliminary dose estimation** | Within 1 hour |---## 2. Dose Assessment### Preliminary Information Collection- **Isotope involved** (I-125, Pd-103, Ir-192, Co-60, etc.)- **Source activity at time of exposure**- **Duration of exposure**- **Distance from source**- **Shielding in...

**Scores:**
- Total: 0.87
- Keyword: 0.62
- Completeness: 1.00
- Safety: 1.00
- Accuracy: 1.00
- Ux: 1.00
- Language: 1.00

**Screenshot:**
![Q0467](../screenshots/17_Q0467.png)

---

### ✅ Q0470

**Input:** A patient with an I-125 seed implant wants to undergo an MRI scan for an unrelated medical condition. Is it safe for this patient to have an MRI? What are the safety considerations and recommendations?...

**Response:**
> # MRI Safety with I-125 Seed Implants## Short Answer**Yes, MRI is generally safe for patients with I-125 seed implants**, but specific conditions apply based on the seed type and MRI field strength.## Key Safety Considerations### 1. Seed CompositionI-125 seeds contain a radioactive isotope (iodine-125) adsorbed onto a metal carrier (usually silver). The seeds have:- Titanium capsule (MRI safe)- No ferromagnetic components- Radioactive material that is not affected by magnetic fields### 2. MRI Compatibility Classification| Classification | Description ||----------------|-------------|| **MRI Safe** | No...

**Scores:**
- Total: 0.96
- Keyword: 0.88
- Completeness: 1.00
- Safety: 1.00
- Accuracy: 1.00
- Ux: 1.00
- Language: 1.00

**Screenshot:**
![Q0470](../screenshots/17_Q0470.png)

---

### ❌ Q0474

**Input:** I need to evaluate the radiation shielding adequacy of our HDR treatment room. The room has 6-inch thick concrete walls. Our Ir-192 source is 37000 U. Is this shielding sufficient for a room adjacent to a public corridor?...

**Response:**
> ## HDR治疗室屏蔽评估：Ir-192源（37000 U）与6英寸混凝土墙### 核心参数| 参数 | 值 ||------|-----|| 放射源 | Ir-192 || 源活度 | 37000 U (= 370 GBq ≈ 10 Ci) || 屏蔽材料 | 混凝土 || 屏蔽厚度 | 6英寸（15.24 cm） || 相邻区域 | 公共走廊（无控区） || Ir-192平均能量 | ~0.38 MeV || Ir-192在混凝土中的半值层(HVL) | ~2.2 cm |### 屏蔽计算**1. 半值层数计算：**```NVL = 15.24 cm ÷ 2.2 cm/HVL = 6.93 HVL```**2. 透射因子：**```T = (1/2)^6.93 = 0.0087 (约0.87%的辐射穿透)```**3. 以典型HDR治疗参数计算：**假设每周...

**Scores:**
- Total: 0.73
- Keyword: 0.22
- Completeness: 1.00
- Safety: 1.00
- Accuracy: 1.00
- Ux: 1.00
- Language: 1.00

**Screenshot:**
![Q0474](../screenshots/17_Q0474.png)

**Failure Analysis:**
- Root Cause: wrong_answer
- Description: Response does not meet expectations

---

### ✅ Q0476

**Input:** We are performing a brachytherapy procedure on a patient who is breastfeeding. The patient is concerned about radiation exposure to her infant. What are the specific safety considerations and recommendations for breastfeeding patients?...

**Response:**
> # Brachytherapy Safety for Breastfeeding Patients## General PrincipleFor most brachytherapy procedures, **breastfeeding can typically continue**. Brachytherapy sources emit localized radiation that does not make the patient systemically radioactive or contaminate breast milk.## Considerations by Treatment Site| Treatment Site | Breastfeeding Recommendation ||----------------|-------------------------------|| **Gynecological** | Continue normally; no milk contamination expected || **Cervical/Uterine HDR** | Safe to continue; infant not present during treatment || **Breast (partial breast irradiation)** | May affect lactation from treated breast; counsel patient || **Head/Neck/Other** | Safe to continue |## Key...

**Scores:**
- Total: 0.95
- Keyword: 0.86
- Completeness: 1.00
- Safety: 1.00
- Accuracy: 1.00
- Ux: 1.00
- Language: 1.00

**Screenshot:**
![Q0476](../screenshots/17_Q0476.png)

---

### ✅ Q0479

**Input:** A radiation therapy student is observing an HDR brachytherapy procedure. What safety precautions must be taken to ensure the student's radiation exposure remains below regulatory limits during the observation?...

**Response:**
> # Safety Precautions for Radiation Therapy Students Observing HDR Brachytherapy Procedures## Regulatory BasisStudents are classified as **radiation workers** and subject to the same dose limits as staff:- **Whole body**: 50 mSv/year (5 rem/year)- **Lens of eye**: 150 mSv/year- **Extremities**: 500 mSv/year- **Embryo/fetus**: 1 mSv for entire pregnancy (if declared pregnant)## Required Precautions During Observation### 1. **Dosimetry**- **Wear a personal dosimeter** (TLD or OSL badge) at all times during observation- Consider a **secondary dosimeter** on the torso for added monitoring- For extended observation periods, consider a **real-time electronic dosimeter** with alarm### 2. **Distance**- Maintain **maximum practical distance** from the patient and source- **6...

**Scores:**
- Total: 1.00
- Keyword: 1.00
- Completeness: 1.00
- Safety: 1.00
- Accuracy: 1.00
- Ux: 1.00
- Language: 1.00

**Screenshot:**
![Q0479](../screenshots/17_Q0479.png)

---

### ✅ Q0480

**Input:** We are considering using 3D-printed applicators for a complex brachytherapy case. What material safety testing and quality assurance procedures are required before using patient-specific 3D-printed applicators clinically?...

**Response:**
> # 3D-Printed Brachytherapy Applicators: Material Safety Testing and QA Protocol## 1. Regulatory Classification and Pathway**FDA Regulatory Framework:**- 3D-printed applicators are typically classified as **Class II medical devices**- The appropriate pathway is typically **510(k) Premarket Notification** or **De Novo** request- Some custom devices may qualify for **Custom Device Exemption (CDE)** under 21 CFR 812.3**Key Considerations:**- Commercial off-the-shelf (OTS) materials used for 3D printing require documented clearance or approval- Patient-specific custom devices may follow custom manufacturing pathways- Institutional fabrication for use within a single institution still requires documented quality...

**Scores:**
- Total: 1.00
- Keyword: 1.00
- Completeness: 1.00
- Safety: 1.00
- Accuracy: 1.00
- Ux: 1.00
- Language: 1.00

**Screenshot:**
![Q0480](../screenshots/17_Q0480.png)

---

### ✅ Q0481

**Input:** A patient with a pacemaker is scheduled for HDR brachytherapy of a breast tumor. The pacemaker is on the contralateral side. What are the electromagnetic interference risks and what precautions should be taken?...

**Response:**
> ## Electromagnetic Interference Considerations for Pacemaker Patients Undergoing HDR Breast Brachytherapy### Key Finding**HDR brachytherapy does NOT pose electromagnetic interference (EMI) risks to pacemakers.** HDR systems use Iridium-192, which produces **gamma radiation** (photons), not electromagnetic interference in the radiofrequency spectrum that could disrupt pacemaker function.### Why EMI Is Not a Concern- **Radiation type**: Ir-192 HDR sources emit gamma rays (~380 keV), which are electromagnetic photons but do not operate at frequencies that interfere with cardiac devices- **Pacemaker vulnerability**: Pacemakers are susceptible to **RF electromagnetic fields** (e.g., MRI, diathermy, electrocautery) and **static magnetic fields**, not therapeutic gamma radiation- **Ionizing vs. non-ionizing**:...

**Scores:**
- Total: 0.94
- Keyword: 0.83
- Completeness: 1.00
- Safety: 1.00
- Accuracy: 1.00
- Ux: 1.00
- Language: 1.00

**Screenshot:**
![Q0481](../screenshots/17_Q0481.png)

---

